Counterforce Health Team

Counterforce Health Team

How to Get Jakafi (Ruxolitinib) Covered by UnitedHealthcare in Pennsylvania: Complete Appeals Guide

Quick Answer: Getting Jakafi Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Jakafi (ruxolitinib) in Pennsylvania. For myelofibrosis, you need intermediate/high-risk disease documentation. For polycythemia vera, you must document hydroxyurea failure after ≥14 days at maximum tolerated dose. Submit PA requests via the UHC Provider Portal or
6 min read

How to Renew Ocrevus (Ocrelizumab) Approval with Humana in New Jersey: 2025 Renewal Requirements and Timeline

Answer Box: Renewing Ocrevus (Ocrelizumab) with Humana in New Jersey Humana requires prior authorization renewal for Ocrevus (ocrelizumab) every 6-12 months, with no grace period for continuation coverage. Start your renewal 30-45 days before your current authorization expires to avoid treatment gaps. Submit updated medical necessity documentation through your provider&
6 min read

How to Get Prolastin-C (Alpha1-Proteinase Inhibitor) Covered by Cigna in Michigan: Complete PA Guide and Appeals Process

Answer Box: Getting Prolastin-C Covered by Cigna in Michigan Cigna requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) with step therapy preference over Zemaira. Key requirements: severe AAT deficiency (genotype Pi*ZZ or equivalent), serum AAT <80 mg/dL, emphysema documentation, and non-smoker status. First step today: Have your pulmonologist
6 min read

How to Get Oxlumo (Lumasiran) Covered by Aetna (CVS Health) in Illinois: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Oxlumo Covered by Aetna (CVS Health) in Illinois Aetna (CVS Health) covers Oxlumo (lumasiran) for primary hyperoxaluria type 1 (PH1) with prior authorization. To get approval: (1) Your nephrologist or geneticist submits a precertification request with confirmed PH1 diagnosis (genetic testing showing AGXT mutation or enzyme analysis)
6 min read

How to Get Mepsevii (Vestronidase Alfa-vjbk) Covered by UnitedHealthcare in Texas: Complete PA Guide and Appeals Process

Answer Box: Getting Mepsevii Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Mepsevii (vestronidase alfa-vjbk) in Texas, with coverage under the medical benefit using HCPCS J3397. Submit PA via OptumRx Provider Portal with confirmed MPS VII diagnosis (enzyme deficiency + GUSB genetics), specialist documentation, and baseline assessments. Standard review
6 min read

How to Get Hemlibra (emicizumab-kxwh) Covered by UnitedHealthcare in Ohio: Complete PA Guide with Forms, Appeals, and State Protections

Answer Box: Getting Hemlibra Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Hemlibra (emicizumab-kxwh) in Ohio with documented hemophilia A diagnosis, bleeding history, and weight-based dosing plan. Ohio law provides step-therapy protections and external review rights. First step: Submit PA through UnitedHealthcare provider portal with complete clinical documentation
6 min read